ITOS - Arcus shares extend gains amid mixed reactions on Gilead stake purchase
2024-01-30 10:22:11 ET
More on Arcus Biosciences
- Arcus Biosciences: Showing There Might Be Something To TIGIT After All
- Arcus Biosciences' Oncology Odyssey: The Domvanalimab Journey
- Arcus Biosciences, Inc. (RCUS) Q3 2023 Earnings Call Transcript
- Gilead invests $320M in Arcus, expands stake to 33%
- Arcus posts early-stage data for Gilead-partnered cancer therapy